STAAR Surgical Company (STAA) Stock

STAAR Surgical Company, headquartered in Lake Forest, California, is a global leader in designing, developing, manufacturing, marketing, and selling implantable lenses and delivery systems for ophthalmic surgery. The company specializes in providing advanced solutions for treating a range of visual disorders, including myopia, hyperopia, astigmatism, and presbyopia through its Visian implantable Collamer lens product family (ICLs). Additionally, STAAR Surgical offers Hyperopic ICLs designed specifically for treating far-sightedness.

In the field of cataract surgery, STAAR Surgical supplies preloaded silicone intraocular lenses and injector systems, enhancing surgical precision and outcomes. The company also distributes injector parts and other related instruments and devices essential for ophthalmic procedures.

With a global presence, STAAR Surgical markets its products directly through its dedicated sales representatives across key markets such as the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore. Internationally, the company reaches customers through a combination of its own representatives and independent distributors in regions including China, Korea, India, France, Benelux, and Italy.

Founded in 1982, STAAR Surgical has established a solid reputation for innovation and quality in the ophthalmic medical device industry. Committed to advancing eye care technology, the company continues to expand its product offerings and geographical reach, ensuring ophthalmologists worldwide have access to state-of-the-art solutions that improve patient vision and quality of life.